Kathy Coffey, President of CBI Research, Inc. recently participated in an intensive, face-to-face learning program on winning in your business and career. The program was led by the world's most celebrated CEO, Jack Welch. The program was limited to 100 executives, who came from companies such as Novartis Pharmaceuticals, Novo Nordisk Pharmaceuticals and Amgen Inc.

Kathy Coffey, President of CBI Research, Inc with Jack Welch

The two-day program aided top-level business executives in sorting out their most urgent strategic challenges and toughest managerial issues. Attendees debated their biggest challenges, and gained insight on different opportunities. Jack Welch urged the attendees to "Come prepared to talk about your own business and career challenges - and to have them addressed straight on."

Sessions at the program included "Leading To Win," "Change & Crisis," "People," "Designing Strategy" and "Growth and Innovation." All the sessions were led by Jack Welch himself.

About Jack Welch

Jack Welch is the most admired CEO in the world. During his 20 years as Chairman and CEO of General Electric, he transformed the company from a bureaucratic behemoth to a dynamic and revered powerhouse. During his tenure, GE's market value grew from $13 billion to $400 billion. In the process, Welch's management innovations made him the most influential CEO of his era. Welch is currently the head of Jack Welch, LLC, where he serves as an advisor to a small group of Fortune 500 business CEOs and speaks to groups of executive entrepreneurs, and students around the world.

About CBI Research, Inc.

CBI is a privately held, world-class conference company that focuses on producing high-level programs for executive decision-makers who face strategic issues in domestic and international markets. CBI has provided information and networking opportunities for thousands of senior- level executives in various industries for nearly ten years. Currently, eighty percent of its events focus on investment opportunities, business strategies, global regulatory issues, operations and applied technologies within the bio/pharmaceutical arena.